Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Genistein |
Synonyms | |
Therapy Description |
Genistein binds to protein tyrosine kinase, inhibiting downstream signaling and promoting differentiation, and also inhibits topoisomerase leading to cell cycle arrest and apoptosis (PMID: 32486630). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Genistein | CI 75610|Prunetol|Genisteol | Genistein binds to protein tyrosine kinase, inhibiting downstream signaling and promoting differentiation, and also inhibits topoisomerase leading to cell cycle arrest and apoptosis (PMID: 32486630). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02624388 | Phase II | Genistein | Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) | Terminated | USA | 0 |
NCT01985763 | Phase Ib/II | Genistein Bevacizumab Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab | Genistein in Treatment of Metastatic Colorectal Cancer | Completed | USA | 0 |
NCT02766478 | Phase II | Genistein | Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer | Terminated | USA | 0 |
NCT01489813 | Phase II | Genistein | Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment | Active, not recruiting | USA | 0 |